| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6107382 | Journal of Hepatology | 2009 | 9 Pages |
Abstract
NAFLD is highly prevalent among psoriasis patients, where it is closely associated with obesity (overall and abdominal), metabolic syndrome, and PsA, and more likely to cause severe liver fibrosis (compared with nonPs-NAFLD). Routine work-up for NAFLD may be warranted in patients with psoriasis, especially when potentially hepatotoxic drug therapy is being considered.
Keywords
NAFLDNFsPSAHDLATPIIINAFLD Fibrosis ScoreγGTALTpsoriatic arthritisLiver function testASTAspartate aminotransferaseAlanine aminotransferaseHomeostatic model assessmentNon-alcoholic steatohepatitisstandard deviationPASInon-alcoholic fatty liver diseaseSteatosisbody mass indexBMIconfidence intervalsFibrosishigh density lipoproteinMethotrexatepsoriasis area and severity indexodds ratioNash HOMAAdult Treatment Panel IIIGamma glutamyl transpeptidase
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Luca Miele, Selenia Vallone, Consuelo Cefalo, Giuseppe La Torre, Carmine Di Stasi, Fabio M. Vecchio, Magda D'Agostino, Maria L. Gabrieli, Vittoria Vero, Marco Biolato, Maurizio Pompili, Giovanni Gasbarrini, Gianludovico Rapaccini, Pierluigi Amerio,